Financial comparisons Virax Biolabs Group Limited

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 09/03/2026 GMT			5-day change	1st Jan Change
0.2000 ^USD	-6.76%		-9.21%	-42.16%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
VIRAX BIOLABS GROUP LIMITED	6.33K	-95,754.34%	-97,360.19%	-	-	-
LONZA GROUP AG	7.25B	9.67%	17.9%	6.77%	3.48%	1.5x
BEONE MEDICINES AG	5.34B	5.37%	8.37%	11.07%	4.42%	-3.99x
CELLTRION, INC.	2.41B	11.88%	13.83%	2.46%	2.14%	1.28x
IQVIA HOLDINGS INC.	16.31B	8.34%	13.38%	32.9%	4.79%	3.63x
ASCENDIS PHARMA A/S	846M	-31.67%	-18.92%	-	-	1.57x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
EUROFINS SCIENTIFIC SE	8.57B	6.51%	14.79%	11.46%	4.17%	2.2x
IONIS PHARMACEUTICALS, INC.	944M	-40.36%	-40.47%	-70.72%	-11.67%	5.33x
TEMPUS AI, INC.	1.27B	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
QIAGEN N.V.	1.98B	4.23%	28.66%	13.31%	8.32%	0.34x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.02B	-3.59%	19.77%	15.46%	6.99%	1.98x
ABIVAX	12.94M	-1,409.6%	-1,383.2%	-148.95%	-	0.4x
BIO-TECHNE CORPORATION	1.22B	6.02%	31.45%	15.37%	11.65%	0.43x
ICON PUBLIC LIMITED COMPANY	8.28B	9.56%	19.29%	12.39%	6.87%	1.66x
KYMERA THERAPEUTICS, INC.	39.21M	-794.04%	-891.07%	-28.49%	-18.41%	3.05x
HANGZHOU TIGERMED CONSULTING CO., LTD	905M	6.14%	7.92%	1.94%	1.39%	0.27x
Average	3.64B	-5,762.78%	-5,853.02%	-6.23%	2.83%	-2.93x
Weighted average by Cap.	5.34B	-65.39%	-59.76%	2.55%	3.54%	-1.40x